News Sections
Audio
FDA Approves Generic Drug For ADHD
Updated May 31, 2017 8:20 AM | Filed under: Health
 Print    Archive    RSS

(UNDATED) - Four drug manufacturers - Apotex Inc., Teva Pharmaceuticals USA Inc., Aurobindo Pharma Ltd. and Glenmark Pharmaceuticals Ltd.- gained U.S. Food and Drug Administration approval to market a generic form of Strattera (atomoxetine) which is used to treat attention-deficit/hyperactivity disorder.

The FDA action came just three days after patent protection expired for the Eli Lilly & Co. drug.



« Previous Article
Next Article »

 Print    Archive    RSS

Have a question or comment about a news story? Send it to comments@wbiw.com

Advertise with 1340 AM WBIW
Find more about Weather in Bedford, IN
Advertise with 1340 AM WBIW


1340 AM WBIW, Bedford's Place To Talk. Serving Lawrence and surrounding counties since 1948!

© 2017 Ad-Venture Media, Inc. All Rights Reserved.   WBIW.com and Listen Live Powered by HPC

Advertise  |  Careers  |  Contests  |  About  |  Feedback